Elbonix (Eltrombopag)
Categories Hematopoietic, Oncology Medicine
Tag Eltrombopag OlamineEltrombopag
Related products
Product Description
Elbonix is an orally bioavailable, small-molecule TPO-receptor agonist that interacts with the transmembrane domain of the human TPO-receptor and initiates signaling cascades that induce proliferation and differentiation from bone marrow progenitor cells.Elbonix is available in tablet form for oral administration.
Product Features:
- Improves chronic ITP & SAA effectively
- Effective in chronic hepatitis C related thrombocytopenia
- Increases & maintains platelet counts